Tag: Lisa Anson

Jazz Pharmaceuticals to acquire Redx Pharma’s KRAS inhibitor program to expand oncology pipeline

businessnewstoday- February 7, 2024

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Redx Pharma plc (AIM: REDX) have entered into a definitive agreement, marking a significant milestone in the development of ... Read More

Clinical-stage Redx Pharma, Jounce Therapeutics sign $425m merger deal

businessnewstoday- February 23, 2023

Redx Pharma, a UK-based clinical-stage biotechnology company, and Jounce Therapeutics, a Nasdaq-listed clinical-stage immunotherapy company, have agreed to merge in an all-stock deal that values ... Read More

Redx Pharma gets $9m as AstraZeneca initiates AZD5055 phase 1 trial

pallavi123- January 3, 2022

UK-based biotech company Redx Pharma said that it has received a milestone payment of $9 million from AstraZeneca following the initiation of a phase 1 ... Read More